Registered entities
Lexeo Therapeutics, Inc
Reg. No. 6323524United States
Social engagement
Social engagement: 17.6K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
28 investors on record; lead investors include Sarepta, Longitude Capital, Omega Funds, Janus Henderson Investors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 14% |
| Private equity | 8 | 29% |
| Angel & family office | 1 | 4% |
| Other / undisclosed | 15 | 54% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
14 Nov 2025 · Sr. Manager, Marketing and Corporate Strategy · New York
Based on job postings tracked across public sources.
Recent activity
22 Jun 2026
Event
BIO International Convention 2026
16 Jun 2026
Event
American Society of Gene & Cell Therapy Annual Meeting
15 Jun 2026
Product launch
LX2006 gene therapy